INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Apyx Medical Corp. &...
May 04 2019 - 11:30AM
Business Wire
The law firm of Kirby McInerney LLP announces that a class
action lawsuit has been filed in the U.S. District Court for the
Middle District of Florida on behalf of those who acquired Apyx
Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX)
securities during the period from August 1, 2018 through April 1,
2019 (the “Class Period”). Investors have until June 17, 2019 to
apply to the Court to be appointed as lead plaintiff in the
lawsuit.
The lawsuit alleges that Apyx failed to disclose to investors:
(i) that the clinical study on the use of J-Plasma for dermal
resurfacing had not met its primary efficacy endpoint; (ii) that,
as a result, the clinical study did not support the Company’s
application for regulatory clearance; and (iii) that, as a result,
the Company was unlikely to receive regulatory approval of J-Plasma
for dermal resurfacing.
On April 1, 2019, Apyx announced that it had withdrawn its
510(k) application for Renuvion, a patented surgical device for use
in dermal surgical procedures, citing concerns raised by the FDA.
Apyx revealed that the FDA had questioned the device’s clinical
results, which differed greatly from two of the investigational
centers used in the study, as well as the potential impact of
certain protocol deviations. On this news, shares of Apyx fell
$2.49 per share, approximately 35.8%, to close at $4.46 on April 2,
2019.
If you acquired Apyx securities, have information, or would like
to learn more about these claims, please contact Thomas W. Elrod of
Kirby McInerney LLP at 212-371-6600, by email at
investigations@kmllp.com, or by filling out this contact form, to
discuss your rights or interests with respect to these matters
without any cost to you.
Kirby McInerney LLP is a New York-based plaintiffs’ law firm
concentrating in securities, antitrust, and whistleblower
litigation. The firm’s efforts on behalf of shareholders in
securities litigation have resulted in recoveries totaling billions
of dollars. Additional information about the firm can be found at
Kirby McInerney LLP’s website: www.kmllp.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190504005003/en/
Kirby McInerney LLPThomas W. Elrod, Esq., (212)
371-6600investigations@kmllp.comwww.kmllp.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Apr 2023 to Apr 2024